The Effect of Inhibition of Renin-Angiotensin System by Valsartan during Hypovolemic Shock and Low Flow Sigmoideal Ischaemia in Pigs

Vascular

Volumn 11, Issue 1, 2003, Pages 45-51

  Yilmaz, E N ^a   Vahl, A C ^b   Van Rij, G L ^a   Vink, G Q M ^a   Brom, H L F ^c   Rauwerda, J A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c Department of Orthopaedic Surgery   (Netherlands)

Author keywords

hypovolemic shock; sigmoideal ischaemia; valsartan

Indexed keywords

ANGIOTENSIN; HEMOGLOBIN; LACTIC ACID; POLYGELINE; VALSARTAN;

ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE; COLON ISCHEMIA; CONTROLLED STUDY; HEART OUTPUT; HYPOVOLEMIC SHOCK; LACTATE BLOOD LEVEL; NONHUMAN; OXYGEN SATURATION; PARAMETER; PRIORITY JOURNAL; PULSE OXIMETRY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION; RESUSCITATION; SPLANCHNIC BLOOD FLOW; STATISTICAL ANALYSIS; SYSTEMIC CIRCULATION;

EID: 12244250748     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721090301100109     Document Type: Article

References (33)

1. Yilmaz, E. N. Vahl, A. C. van Rij, G. L. et al. The renin-angiotensin system in swine during hypovolemic shock combined with a low-flow ischaemia of the sigmoid colon. Cardiovascular Surgery, 1999, 7 (5), 539-544.
2. Bailey, R. W. Hamilton, S. R. Morris, J. B. et al. Pathogenesis of nonocclusive ischemic colitis. Ann Surg, 1986, 20 (6), 590-599.
3. McNeill, J. R. and Pang, C. C. Effect of phenobarbital anesthesia and surgery on the control of arterial pressure and mesenteric resistance in cats: role of vasopressin and angiotensin. Can J Physiol Pharmac, 1982, 60, 363-368.
4. Straoukine, M. Devidendt, J. Decoodt, P. et al. Relationships between plasna epinephrine, norepinephrine, dopamine and angiotensin II concentrations, renin activity, hemodynamic state and prognosis in acute heart failure. Acta Cardiol (Brux), 1984, 39, 131-138.
5. Gasic, S. Heinz, G. Kleinbloesem, C. et al. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man. Br J Clin Pharmac, 1989, 27, 225S-234S.
6. Aneman, A. Pettersson, A. Eisenhofer, G. et al. Sympathetic and renin-angiotensin system activation during graded hypovolemia in pigs: impact on mesenteric perfusion and duodenal mucosal function. Shock, 1997, 8 (5), 378-384.
7. Cody, R. J. The clinical potential of renin inhibitors and angiotensin antagonists. Drugs, 1994, 47, 586-598.
8. Markham, A. and Goa, K. Valsartan, a review of its pharmacology and therapeutic use in essential hypertension. Drugs, 1997, 54 (2), 299-311.
9. Awan, N. A. and Mason, D. T. Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure. Am Heart J, 1996, 131, 177-185.
10. Tallant, E. A. and Ferrario, C. M. Biology of angiotensin II recptor inhibition with a focus on losartan: a new drug for the treatment of hypertension. Expert Opin Invest Drug, 1996, 5, 1201-1214.
11. Timmermans, P. B. M. W. M. Wong, P. C. and Chiu, A. T. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev, 1993, 45 (2), 205-251.
12. Csajka, C. Buclin, T. and Brunner, H. R. Pharmatokinetic-pharmacodynamic profile of angiotensin II receptor antagonists. Clin Pharmacokinet, 1997, 32 (1), 1-29.
13. Bauer, J. H. and Reams, G. P. The angiotensin II type 1 receptor antagonists: a new class of antihypertensive drugs. Arch Intern Med, 1995, 155, 1361-1368.
14. Spinale, F. G. Gasparo de, M. Whitebread, S. et al. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. Circulation, 1997, 96 (7), 2385-2396.
15. Kvietys, P. R. Miller, T. and Granger, D. N. Intrinsic control of colonic blood flow and oxygenation. Am J Physiol, 1980, 238, 478-484.
16. Gasic, S. Kleinbloesem, C. H. Heinz, G. et al. Contribution of splanchnic and peripheral vascular tissues to the disposal of angiotensin II and to regional conversion rates of angiotensin I: A pilot study in humans. J Cardiovascular Pharmacology, 1991, 17, 615-620.
17. Lees, K. R. MacFayden, R. J. Doig, J. K. et al. Role of angiotensin in extra vascular system. J Human Hypertension, 1993, 7 (Suppl. 2), S7-S12.
18. Griendling, K. K. and Alexander, R. W. The angiotensin (AT1) receptor. Semin Neph Rol, 1993, 13 (6), 558-566.
19. Okamura, T. Aimi, Y. Kimura, H. et al. Existence of renin in the endothelium of human artery. J Hypertension, 1992, 10, 49-53.
20. Brunner, H. R. Nussberger, J. and Waeber, B. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system. J Hypertension, 1993, 11 (Suppl. 3), S53-S58.
21. Swales, S. S. and Samani, N. J. Vascular RAA system. J Human Hypertension, 1993, 7 (Suppl 2), S3-S6.
22. Vahl, A. C. Rij van, G. L. Visser, J. J. et al. Endoluminale pulse oximetry in ischemic colon in a swine model. J Am Coll Surg, 1995, 180, 57-64.
23. Hennessy, A. Barry, M. C. McGee, H. et al. Quality of life following repair of ruptured and elective abdominal aortic aneurysms. Eur J Surg, 1998, 164, 673-677.
24. Prance, S. E. Wilson, Y. G. Cosgrove, C. M. et al. Ruptured abdominal aortic aneurysms: Selecting patients for surgery. Eur J Vase Endovasc Surg, 1999, 17, 129-132.
25. Dongen van, H. P. A. Leusink, J. A. Moll, F. L. et al. Ruptured abdominal aortic aneurysms: Factors influencing postopeartive mortality and long-term survival. Eur J Vase Endovasc Surg, 1998, 15, 62-66.
26. Sebesta, P. Klika, T. Zdrahal, P. et al. Ruptured abdominal aortic aneurysm: Role of initial delay on survival. J Mal Vasc, 1998, 23 (5), 361-367.
27. Barry, M. C. Burke, P. E. Sheehan, S. et al. An “all comers” policy for ruptured abdominal aortic aneurysms: How can results be improved? Eur J Surg, 1998, 164, 263-270.
28. Buckley, G. B. Oshma, A. and Bailey, R. W. Control of gastric vascular resistance in cardiogenic shock. Surgery, 1985, 98, 213.
29. Cullen, J. J. Ephgrave, K. S. Broadhurst, K. A. et al. Captoril decreases stress ulceration without affecting gastric perfusion during canine hemorrhagic shock. J Trauma, 1994, 37 (1), 43-49.
30. Jakschik, J. Decker, P. and Hirner, A. The importance of the therapy time point for the effect of systemic and local therapy with the ACE inhibitor captopril on intestinal microcirculation in nonocclusive mesenteric ischemia, langenbecks. Arch Chir, 1995, 380, 273-280.
31. Rozsa, Z. and Sonkodi, S. The effect of long term oral captopril treatment on mesenteric blood flow on spontaneously hypertensive rats. Pharmacological Research, 1995, 32 (1), 21-25.
32. Abdelrahman, A. M. Burrell, L. M. and Johnston, C. I. Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone. J Hypertension, 1993, 11 (suppl 3), S23-S26.
33. Muller, P. Flesch, G. Gasparo de, M. et al. Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects. Eur J Clin Pharmacol, 1997, 52, 441-449.